Stadovas 10 Tab

Amlodipine exerts antihypertensive action by a direct vasodilating effect on the smooth muscles surrounding the peripheral arterial blood vessels, with less effect on the cardiac muscle calcium channels. Amlodipine therefore does not worsen atrioventricular (AV)-conduction in heart, and amlodipine does not give any negative inotropic effect.

Pack size Box of 30 tablets/ 50 tablets/ 100 tablets
Shelf-life 24 months
Composition Amlodipine
Dosage forms and strengths Tablet: 10 mg
Product code :



Hypertension. Chronic stable angina pectoris. Vasospastic (Prinzmetal’s) angina.


  • Adults: For both hypertension (in combination with a thiazide diuretic, alpha blocker, beta blocker, or an angiotensin converting enzyme inhibitor) and angina (monotherapy or in combination with other anti-anginal medicinal products in patients with angina that is refractory to nitrates and/or to adequate doses of beta blockers), the initial dose is 5 mg amlodipine once daily which may be increased to a maximum dose of 10 mg depending on the individual patient’s response.
  • Children with hypertension from 6 – 17 years of age: The starting dose is 2.5 mg once daily (using other suitable preparation), up-titrated to 5 mg once daily if blood pressure goal is not achieved after 4 weeks.
  • Elderly: Increase of the dosage should take place with care.
  • Hepatic impairment: Start at the lower end of the dosing range. Amlodipine should be titrated slowly and monitor closely in patients with severe hepatic impairment.


Drug is orally administered.

  • Known hypersensitive to any of the active substance or excipients of the product.
  • Severe hypotension.
  • Shock (including cardiogenic shock).
  • Obstruction of the outflow tract of the left ventricle (e.g. high grade aortic stenosis).
  • Haemodynamically unstable heart failure after acute myocardial Infarction.
  • Somnolence, dizziness, headache (especially at the beginning of the treatment).
  • Palpitations
  • Flushing
  • Abdominal pain, nausea.
  • Ankle swelling.
  • Oedema, fatigue.
  • Patients with heart failure should be treated with caution.
  • Use in pregnancy is only recommended when there is no safer alternative and when the disease itself carries greater risk for the mother and foetus. A decision on whether to discontinue breast-feeding or to discontinue therapy with amlodipine should be made taking into account the benefit of breast-feeding to the child and the benefit of amlodipine therapy to the mother.
  • Patients should be aware of how they react to drug before driving or operating machinery.